0
0
1/21/23 at 5:01pm
Organization
Dovepress.com
Author
Dove Press
36 words
0
Comments
The aim of this review is to critically summarize experimental and clinical data of fibroblast growth factor-21 in nonalcoholic fatty liver disease.
You are the first to view
https://www.dovepress.com/fibroblast-growth-factor-21-as-a-potential-therapeutic-target-of-nonal-peer-reviewed-fulltext-article-TCRM
Create an account
or login to join the discussion